Publications by authors named "Alexandre M do Nascimento"

The cerebral dopamine neurotrophic factor (CDNF) is a neurotrophic factor extensively studied in the central nervous system because of its neuroprotective effects; however, its role in the peripheral nervous system (PNS) remains less explored. In this study, we used primary dorsal root ganglia (DRG) explants to investigate the neuritogenic potential of exogenous CDNF, as well as its neuroprotective activity under trophic factor deprivation. Our findings demonstrate that CDNF-mediated neuroprotection remains unaffected by the addition of a Trk (tropomyosin receptor kinase) inhibitor or anti-nerve growth factor (NGF) antibody, indicating that CDNF's neurotrophic activity is independent of TrkA signaling.

View Article and Find Full Text PDF

Understanding the signaling mechanisms leading to neurogenic inflammation, a process found in chronic pain, psoriasis and migraine, is key for the development of more effective analgesics. A key player in the onset of this inflammation is transient receptor potential cation channel, subfamily V, member 1 (TRPV1), an ion channel abundant at the free terminals of nociceptors, which can be directly activated by capsaicin (CAP), acidic pH or noxious heat, and indirectly through phospholipase C-γ (PLCγ), which promotes cleavage of the inhibitory phosphatidylinositol-4,5-bisphosphate from the channel. In turn, PLCγ is activated via its phosphorylation by growth factor receptor tyrosine kinases, such as the high affinity nerve growth factor receptor, tropomyosin kinase A (TrkA).

View Article and Find Full Text PDF
Article Synopsis
  • Developing new painkillers is tough because many potential drugs have serious side effects due to their impact on various biological pathways beyond just pain relief.
  • Researchers are focusing on targeting protein-protein interactions (PPIs) involved in pain signaling to create more effective and safer analgesics, using rodent models to evaluate their pain-reducing abilities.
  • By analyzing data from sensory nerve tissues, they identified key PPIs for exploring new drug designs, suggesting that blocking specific interactions in relevant proteins may improve pain treatment while minimizing unwanted effects.
View Article and Find Full Text PDF